Related Experiment Videos
Evidence-based medicine: lung volume reduction surgery (LVRS)
H G Koebe1, C Kugler, H Dienemann
1Schwerpunkt Thoraxchirurgie, Klinikum Kassel, Germany.
The Thoracic and Cardiovascular Surgeon
|October 11, 2002
Summary
Lung volume reduction surgery (LVRS) can improve pulmonary function and quality of life for severe emphysema patients. Careful patient selection is crucial, as LVRS poses risks for some individuals with homogenous emphysema.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Respiratory Medicine
Background:
- Severe pulmonary emphysema necessitates advanced treatment options.
- Lung volume reduction surgery (LVRS) is a surgical intervention for emphysema.
- Previous studies show improved pulmonary function and quality of life post-LVRS.
Purpose of the Study:
- To review current literature on LVRS.
- To provide evidence for patient selection criteria.
- To identify subsets of patients who benefit from LVRS for advanced COPD palliation.
Main Methods:
- Review of published studies on LVRS.
- Analysis of patient selection criteria and surgical techniques.
- Evaluation of outcomes including pulmonary function, quality of life, morbidity, and mortality.
Main Results:
- Stapler device wedge excision is the standard for heterogeneous emphysema.
- LVRS, via VATS or thoracotomy, can reduce dyspnea and oxygen dependency.
- Improvements in spirometry and physical capacity are observed in responders.
- Functional improvement peaks within six months, necessitating post-operative care.
Conclusions:
- LVRS can be an effective palliative treatment for selected advanced COPD patients.
- Careful patient selection is critical to mitigate risks, especially for those with homogenous emphysema.
- Systematic postoperative care is essential for sustained benefits.
- Further long-term data from trials like NETT will clarify LVRS impact on survival.